The Ultra-Rich Intensive Moisturizer by Eighth Day, developed by dermatologic surgeon Dr. Antony Nakhla, is touted as a skincare innovation "where biotech meets clinical volume restoration." This fragrance-free moisturizer is ideal for those with dry and mature skin, as well as GLP-1 users experiencing facial volume loss as a result of treatment.
Some of the key components of this indulgent moisturizer include proprietary, patent-pending Peptide-rich Plasma—24 bioidentical peptides, amino acids, and growth factors that mimic the skin’s inherent renewing abilities—VolumatrixSubQ to support lipid renewal and promote collagen production, and a mix of low, medium, and high molecular weight hyaluronic acid to address multiple layers of skin.
As GLP-1 usage rises, skincare brands have a unique opportunity to develop targeted solutions addressing facial volume loss and skin laxity commonly experienced after rapid weight loss.
What Makes This Trend Stand Out
- Biotech-enhanced Skincare
- Biotech-infused moisturizers are emerging as a solution for restoring skin volume, integrating scientific advancements into everyday skincare routines.
- Targeted Skincare for GLP-1 Users
- Skincare products are increasingly being designed to address the specific needs of GLP-1 users, who often face unique challenges such as facial volume loss.
- Multilayer Hyaluronic Acid Treatment
- The incorporation of hyaluronic acid of varying molecular weights in moisturizers is revolutionizing hydration by targeting different layers of the skin.
Sectors Adopting This
- Dermatological Products
- Dermatology is seeing a surge in personalized skincare innovations tailored for individuals undergoing medical treatments like GLP-1 therapy.
- Biotechnology in Cosmetics
- As biotechnology advances, its application in cosmetics is creating cutting-edge products that enhance skin health and appearance.
- Nutraceutical and Pharma-beauty Crossovers
- The intersection of nutraceuticals and beauty products is leading to formulations that cater to those experiencing pharmaceutical side effects.